Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Juan Zhao, Xinrong He, Mei Zuo, Xinguo Li & Zhiming Sun. (2021) Anagliptin prevented interleukin 1β (IL-1β)-induced cellular senescence in vascular smooth muscle cells through increasing the expression of sirtuin1 (SIRT1). Bioengineered 12:1, pages 3968-3977.
Read now
Read now
Hiroyuki Ito, Suzuko Matsumoto, Takuma Izutsu, Eiji Kusano, Shinya Nishio, Shinichi Antoku, Tomoko Yamasaki, Toshiko Mori, Michiko Togane, Shigenori Ando & Emiko Tsugami. (2019) Comparison of the changes in the factors associated with the renal prognosis of non-elderly and elderly subjects treated with empagliflozin- a retrospective observation study in Japanese patients with type 2 diabetes. Diabetes, Metabolic Syndrome and Obesity 12, pages 1783-1794.
Read now
Read now
Yunxiang Ma, Junkai Wang, Changhua Wang, Qiong Zhang, Yannan Xu, Huajin Liu, Xia Xiang & Jiangwei Ma. (2019) DPP-4 inhibitor anagliptin protects against hypoxia-induced cytotoxicity in cardiac H9C2 cells. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 3823-3831.
Read now
Read now
Zhenbo Chen, Shanwei Tao, Xiaohui Li, Xudong Zeng, Mirong Zhang & Qinghe Yao. (2019) Anagliptin protects neuronal cells against endogenous amyloid β (Aβ)-induced cytotoxicity and apoptosis. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 2213-2220.
Read now
Read now
Aiqin Gong, Jie Xu, Dangqin Jin, Yuanyou Wang & Xiashi Zhu. (2018) Determination of Anagliptin in Serum by Mixed-Hemimicelle Magnetic Solid-Phase Extraction with Surfactant-Coated Iron(II,III) Nanocomposites and High-Performance Liquid Chromatography. Analytical Letters 51:15, pages 2415-2428.
Read now
Read now
Hiroyuki Ito, Masahiro Shinozaki, Shinya Nishio & Mariko Abe. (2016) SGLT2 inhibitors in the pipeline for the treatment of diabetes mellitus in Japan. Expert Opinion on Pharmacotherapy 17:15, pages 2073-2084.
Read now
Read now
Articles from other publishers (11)
Toru Ogura & Chihiro Shiraishi. (2023) Comparison of Adverse Events Occurred During Administration of Dipeptidyl Peptidase-4 Inhibitor in Patients with Diabetes Using FDA Adverse Event Reporting System. Clinical Drug Investigation 43:2, pages 129-140.
Crossref
Crossref
Hongjin Zhai, Shuo Zhang, Maxwell Ampomah-Wireko, Huanhuan Wang, Yaquan Cao, Pu Yang, Yingxue Yang, Firas Obald Arhema Frejat, Lihong Wang, Bingbing Zhao, Changzhong Ren & Chunli Wu. (2022) Pyrazole: An Important Core in Many Marketed and Clinical Drugs. Russian Journal of Bioorganic Chemistry 48:6, pages 1175-1189.
Crossref
Crossref
Tsun-Thai Chai, Clara Chia-Ci Wong, Mohamad Zulkeflee Sabri & Fai-Chu Wong. (2022) Seafood Paramyosins as Sources of Anti-Angiotensin-Converting-Enzyme and Anti-Dipeptidyl-Peptidase Peptides after Gastrointestinal Digestion: A Cheminformatic Investigation. Molecules 27:12, pages 3864.
Crossref
Crossref
Ran Zhang, Rick Oerlemans, Chao Wang, Lili Zhang & Matthew R. Groves. 2022. Drug Repurposing - Molecular Aspects and Therapeutic Applications. Drug Repurposing - Molecular Aspects and Therapeutic Applications.
Sibhghatulla Shaikh, Eun-Ju Lee, Khurshid Ahmad, Syed-Sayeed Ahmad, Jeong-Ho Lim & Inho Choi. (2021) A Comprehensive Review and Perspective on Natural Sources as Dipeptidyl Peptidase-4 Inhibitors for Management of Diabetes. Pharmaceuticals 14:6, pages 591.
Crossref
Crossref
Pietro Delre, Fabiana Caporuscio, Michele Saviano & Giuseppe Felice Mangiatordi. (2020) Repurposing Known Drugs as Covalent and Non-covalent Inhibitors of the SARS-CoV-2 Papain-Like Protease. Frontiers in Chemistry 8.
Crossref
Crossref
Maryam Rameshrad, Bibi Marjan Razavi, Gordon A. A. Ferns & Hossein Hosseinzadeh. (2019) Pharmacology of dipeptidyl peptidase-4 inhibitors and its use in the management of metabolic syndrome: a comprehensive review on drug repositioning. DARU Journal of Pharmaceutical Sciences 27:1, pages 341-360.
Crossref
Crossref
Elliot J. Glotfelty, Thomas E. Delgado, Luis B. Tovar-y-Romo, Yu Luo, Barry J. Hoffer, Lars Olson, Tobias E. Karlsson, Mark P. Mattson, Brandon K. Harvey, David Tweedie, Yazhou Li & Nigel H. Greig. (2019) Incretin Mimetics as Rational Candidates for the Treatment of Traumatic Brain Injury. ACS Pharmacology & Translational Science 2:2, pages 66-91.
Crossref
Crossref
Charu P. Pandya & Sadhana J. Rajput. (2018) Stress Degradation Studies of Anagliptin, Development of Validated Stability Indicating Method, Degradation Kinetics Study, Identification and Isolation of Degradation Products. Chromatographia 81:11, pages 1533-1550.
Crossref
Crossref
Hidetaka Hamasaki & Yasuteru Hamasaki. (2018) Efficacy of anagliptin as compared to linagliptin on metabolic parameters over 2 years of drug consumption: A retrospective cohort study. World Journal of Diabetes 9:10, pages 165-171.
Crossref
Crossref
Lina Rozano, Muhammad Redha Abdullah Zawawi, Muhamad Aizuddin Ahmad & Indu Bala Jaganath. (2017)
Computational Analysis of
Gynura bicolor
Bioactive Compounds as Dipeptidyl Peptidase-IV Inhibitor
. Advances in Bioinformatics 2017, pages 1-16.
Crossref
Crossref